[The association of aromatic microbial metabolites, inflammatory and autoimmune biomarkers with clinical dynamics in severe diseases of the central nervous system].
Ekaterina A ChernevskayaS A ZozulyaNatalia V BeloborodovaT P KlyushnikI V BuyakovaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)
The results suggest the involvement of AMM and the level of immune activation via biomarkers in the pathogenesis of neurological dysfunction. Dynamic changes in the profile of microbial metabolites and the level of activation of the immune system may be a promising tool for prediction of neurological recovery.